Personalized Medicine: Progress and Promise

被引:225
|
作者
Chan, Isaac S. [1 ,2 ,3 ]
Ginsburg, Geoffrey S. [1 ,3 ]
机构
[1] Duke Univ, Ctr Genom Med, Inst Genome Sci & Policy, Durham, NC 27708 USA
[2] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA
[3] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA
关键词
genomic medicine; pharmacogenomics; translational medicine; clinical decision support; comparative effectiveness research; CLINICAL DECISION-SUPPORT; CORONARY-ARTERY-DISEASE; GENOME-WIDE ASSOCIATION; CELL LUNG-CANCER; METASTATIC BREAST-CANCER; GENE-EXPRESSION PATTERNS; HEPATITIS-C VIRUS; FAMILY-HISTORY; MOLECULAR CLASSIFICATION; LINKAGE DISEQUILIBRIUM;
D O I
10.1146/annurev-genom-082410-101446
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Personalized medicine is a broad and rapidly advancing field of health care that is informed by each person's unique clinical, genetic, genomic, and environmental information. Personalized medicine depends on multidisciplinary health care teams and integrated technologies (e.g., clinical decision support) to utilize our molecular understanding of disease in order to optimize preventive health care strategies. Human genome information now allows providers to create optimized care plans at every stage of a disease, shifting the focus from reactive to preventive health care. The further integration of personalized medicine into the clinical workflow requires overcoming several barriers in education, accessibility, regulation, and reimbursement. This review focuses on providing a comprehensive understanding of personalized medicine, from scientific discovery at the laboratory bench to integration of these novel ways of understanding human biology at the bedside.
引用
收藏
页码:217 / 244
页数:28
相关论文
共 50 条
  • [1] Personalized cancer medicine: era of promise and progress
    Hutchinson, Lisa
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (03) : 121 - 121
  • [2] Personalized cancer medicine: era of promise and progress
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2011, 8 : 121 - 121
  • [3] Promise of personalized medicine
    Shreffler, Wayne G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (06) : 534 - 534
  • [4] Personalized Medicine: Challenge and Promise
    Judith Salmon Kaur
    Daniel G. Petereit
    Journal of Cancer Education, 2012, 27 (Suppl 1) : 12 - 17
  • [5] Pharmacogenetics and the Promise of Personalized Medicine
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2018, 3 (05) : 408 - 408
  • [6] Personalized medicine: The promise, the reality
    Campos-Outcalt, Doug
    JOURNAL OF FAMILY PRACTICE, 2007, 56 (08): : 621 - 626
  • [7] Achieving the Promise of Personalized Medicine
    Reynolds, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) : 401 - 405
  • [8] Delivering on the promise of personalized medicine
    Mills, Gordon B.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [9] Pharmacogenomics: The promise of personalized medicine
    Mancinelli L.
    Cronin M.
    Sadée W.
    AAPS PharmSci, 2 (1): : 29 - 41
  • [10] The Promise of Nanotechnology in Personalized Medicine
    Alghamdi, Maha Ali
    Fallica, Antonino N.
    Virzi, Nicola
    Kesharwani, Prashant
    Pittala, Valeria
    Greish, Khaled
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):